I. Ostmansmith et al., DILATED CARDIOMYOPATHY DUE TO TYPE-II X-LINKED 3-METHYLGLUTACONIC ACIDURIA - SUCCESSFUL TREATMENT WITH PANTOTHENIC-ACID, British Heart Journal, 72(4), 1994, pp. 349-353
A case of dilated cardiomyopathy in a young boy secondary to type II 3
-methyl-glutaconic aciduria is described. A metabolic cause for his di
lated cardiomyopathy was suspected because of the development on the e
lectrocardiogram of an unusual ''camel's hump'' shape of the T waves,
and of progressive thickening with increasing echogenicity of the left
ventricular wall. He initially improved on digoxin treatment, but did
not maintain the response with conventional dietary treatment for thi
s condition. Supplementation with L-carnitine was associated with rapi
d deterioration in cardiac state, and may be contraindicated in this c
ondition. At a point when the patient was moribund, large doses of pan
tothenic acid, a precursor of coenzyme A, produced a dramatic and sust
ained improvement in myocardial function and in growth, neutrophil cel
l count, hypocholesterolaemia, and hyperuricaemia, which suggests that
limitation of availability of coenzyme A is a fundamental pathologica
l process in this condition. The clinical improvement has been maintai
ned for 13 months, and myocardial function is now nearly normal. Oral
pantothenol, unlike pantothenic acid, is not efficacious.